Group-based TSC intervention mediates improvements in depression and anxiety via insomnia severity in adults with MDD.
This study utilized a secondary analysis of a randomized controlled trial involving 152 adults (mean age 34.0 years; 79.6% female) with major depressive disorder. Participants received a group-based Transdiagnostic Intervention for Sleep and Circadian Dysfunction compared with care-as-usual. The analysis focused on mediation pathways rather than primary clinical outcomes or safety data.
Standardized indirect effects demonstrated that reductions in insomnia symptom severity, sleep disturbance, and sleep-related impairment were significantly mediated by sleep diary-derived parameters. Specifically, effects ranged from -0.06 to -0.17 for insomnia, -0.04 to -0.22 for disturbance, and -0.04 to -0.17 for impairment. Sequential mediation analysis revealed that treatment effects on depressive symptoms (-0.05 to -0.10), anxiety (-0.04 to -0.07), fatigue (-0.05 to -0.09), functional impairment (-0.06 to -0.09), and quality of life (0.04 to 0.08) were driven by insomnia severity; sleep-diary parameters alone did not mediate effects.
Further analysis indicated that the severity of insomnia symptoms alone mediated treatment effects (standardized indirect effects 0.09 to 0.17), whereas sleep parameters alone did not (0.00 to 0.07). Key limitations include the secondary analysis design and the observational nature of the mediation analysis, which precludes establishing direct causation. These findings underscore the critical role of subjective sleep measures in clinical improvements within sleep-targeted interventions for depression.